US FDA warns of dosing errors with compounded versions of Novo's weight loss drugs-February 2024-www.financetom.com

US FDA warns of dosing errors with compounded versions of Novo's weight loss drugs

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA warns of dosing errors with compounded versions of Novo's weight loss drugs

Jul 26, 2024 7:12 AM

July 26 (Reuters) - The U.S. Food and Drug

Administration on Friday warned patients and doctors about

dosing errors associated with compounded versions of Novo

Nordisk's weight loss and diabetes drugs.

(Reporting by Mariam Sunny in Bengaluru; Editing by Shinjini

Ganguli)

Previous page： PepsiCo Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts Next page： CeriBell Prices IPO at $17 per Share

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

PepsiCo Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Oct 11, 2024

PepsiCo, Inc. ( PEP ) will release earnings results for its third quarter, before the opening bell on Tuesday, Oct. 8. Analysts expect the Purchase, New York-based company to report quarterly earnings at $2.30 per share, up from $2.25 per share in the year-ago period. PepsiCo ( PEP ) projects to report revenue of $23.85 billion for the quarter, compared...

CeriBell Prices IPO at $17 per Share

Oct 11, 2024

03:11 AM EDT, 10/11/2024 (MT Newswires) -- CeriBell (CBLL) said late Thursday it priced its initial public offering of 10.6 million common shares at $17 per share for expected gross proceeds of $180.3 million. The underwriters have been granted a 30-day option to purchase up to 1.6 million additional shares. The offering is expected to close on Oct. 15, subject...

Nippon Steel to sell Calvert JV to ArcelorMittal if U.S. Steel deal completed

Oct 11, 2024

TOKYO (Reuters) - Nippon Steel said on Friday it will sell its entire 50% stake in the joint venture steel plant in Calvert, Alabama, with ArcelorMittal if the top Japanese steelmaker's buyout bid for United States Steel is successful. Nippon Steel would book consolidated loss of about 230 billion yen ($1.55 billion) upon its sale of the NS Kote holding...

Porsche's nine-month China sales plunge by third

Oct 11, 2024

STUTTGART (Reuters) - German sports car maker Porsche on Friday posted a 29% nine-month sales drop in China, joining peers BMW and Mercedes in reporting weaker results in the country. The slump in China, the world's biggest car market, and the ongoing model revamp weighed on the overall result, with global sales falling by 7% to 226,026 units in January-September....